Sponsor content
818 result(s) found, displaying 151 to 160
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VALTRESTO sacubitril/valsartan (combined as sodium salts) 49/51 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VALTRESTO sacubitril/valsartan (combined as sodium salts) 49/51 mg film-coated tablet bottle pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VALTRESTO sacubitril/valsartan (combined as sodium salts) 97/103 mg film-coated tablet bottle pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SACUBITRIL/VALSARTAN-WGR sacubitril/valsartan (combined as sodium salts) 97/103 mg film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHARMACOR SACUBITRIL/VALSARTAN sacubitril/valsartan (combined as sodium salts) 97/103 mg film-coated tablet bottle pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHARMACOR SACUBITRIL/VALSARTAN sacubitril/valsartan (combined as sodium salts) 24/26 mg film-coated tablet bottle pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PHARMACOR TICAGRELOR ticagrelor 90 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BRICALOR ticagrelor 90 mg tablet blister pack.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2024
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 29/01/2024